Tech Daily Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Missouri.

Press releases published on November 2, 2026

Nov. 2, 2026

Humanoid Global Highlights Portfolio Company Formic’s US$50 Million Raise, Led by Mercato Partners, to Advance Physical AI Across American Manufacturing

Indeterminate GlobeNewswire

Nov. 2, 2026

Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer

Indeterminate GlobeNewswire

Nov. 2, 2026

Trust Stamp announces presentation on Company’s progress and 2027 Business Plan

Indeterminate GlobeNewswire

Nov. 2, 2026

Micware Expands North American Presence with Relocation of U.S. Office in Dublin, Ohio

Indeterminate GlobeNewswire

Nov. 2, 2026

Leonardo DRS Selected by AV for U.S. Army’s Enduring-High Energy Laser Production Program

Indeterminate GlobeNewswire

Nov. 2, 2026

Inuvo’s IntentKey Puts Custom Audiences Live on Safari and iPhone Within 24 Hours

Indeterminate GlobeNewswire

Nov. 2, 2026

BacBit Unveils Next-Generation AI-Driven Digital Asset Trading Ecosystem

Indeterminate GlobeNewswire

Nov. 2, 2026

NowVertical Announces Release of Units from Escrow to Teraz Fund

Indeterminate GlobeNewswire

Nov. 2, 2026

Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach

Indeterminate GlobeNewswire

Nov. 2, 2026

A3P Biomedical appoints Matt Franklin as President, North America to accelerate US market access for Stockholm3

Indeterminate GlobeNewswire

Nov. 2, 2026

Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis

Indeterminate GlobeNewswire

Nov. 2, 2026

CytomX Therapeutics to Present at Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud

Indeterminate GlobeNewswire

Nov. 2, 2026

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

Eyconis to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026

Indeterminate GlobeNewswire